Novartis in Lincoln reduced it's temporary employee workforce by 160 people.
Novartis released the information through a statement Saturday. It did not say when the employees were notified and Novartis did not explain why the workers were released.
However, the plant in Lincoln shut down in the end of December after a problem caused powerful prescription pain pills to get mixed up with over-the-counter drugs.
Novartis voluntarily recalled bottles of Excedrin, Bufferin, Gas-X and No-Doz.
The statement says Novartis is "working toward a plan to resume manufacturing and they expect to start shipments mid-year."
It goes on to say they expect approximately 40 temporary workers to stay on to work in manufacturing and packaging.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.